# DurAVR™ THV System: First-In-Human Study

> **NCT05182307** · NA · UNKNOWN · sponsor: **Anteris Technologies Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Symptomatic Aortic Stenosis
- Severe Aortic Valve Stenosis
- Aortic Valve Calcification

## Interventions

- **DEVICE:** DurAVR™ THV System

## Key facts

- **NCT ID:** NCT05182307
- **Lead sponsor:** Anteris Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-15
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05182307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05182307, "DurAVR™ THV System: First-In-Human Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05182307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*